vimarsana.com
Home
Live Updates
Tenaya Therapeutics, Inc.: Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress : comparemela.com
Tenaya Therapeutics, Inc.: Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today
Related Keywords
United States ,
Leone Patterson ,
Kostenloser Wertpapierhandel ,
Wendy Ryan ,
Laura Lombardi ,
European Society Of Gene ,
Nasdaq ,
Gene Transfer Prevents Development Of Arrhythmogenic Cardiomyopathy ,
Tenaya Therapeutics Inc ,
Exchange Commission ,
University Of Texas Southwestern Medical Center ,
Securities Exchange ,
Tenaya Therapeutics ,
Annual Congress ,
European Society ,
Cell Therapy ,
Premature Lethality ,
Cardiac Hypertrophy ,
Associate Director ,
Gene Therapy Biology ,
Transfer Prevents Development ,
Arrhythmogenic Cardiomyopathy ,
Gladstone Institutes ,
Texas Southwestern Medical Center ,
Gene Therapy ,
Cellular Regeneration ,
Looking Statements ,
Securities Act ,
Securities Exchange Act ,
Bridge Communications ,
Tenaya ,
Herapeutics ,
Present ,
Reclinical ,
Data ,
Gene ,
Therapy ,
Programs ,
Sgct ,
8th ,
Nnual ,
Congress ,
comparemela.com © 2020. All Rights Reserved.